Results 51 to 60 of about 231 (96)

Delphi-based Spanish consensus on the use of long-acting growth hormone in pediatric growth hormone deficiency: recommendations from the ConverGHe Working Group. [PDF]

Front Endocrinol (Lausanne)
Castro-Feijóo L, Labarta-Aizpún JI, Ramon-Krauel M, Primiano D, Yeste Fernández D, González Casado I.   +5 more
europepmc   +1 more source

Long-Acting Growth Hormone for Pediatric Growth Hormone Deficiency. [PDF]

J Endocr Soc
Albers N, Cadarette S, Feakins B, Arregui M, Ebohon S, Lai P, Raveendran S, Kjelgaard-Hansen M, Andersen C, Zhao C, Smith A, Geffner M.   +11 more
europepmc   +1 more source

Current understanding and perspectives on growth and long-acting GH therapy in Japan. [PDF]

Clin Pediatr Endocrinol
Hasegawa Y, Ikegawa K, Mitani-Konno M, Ariyasu D, Amano N.   +4 more
europepmc   +1 more source

Rationale for Long-acting Growth Hormone Therapy and Future Aspects [PDF]

J Clin Res Pediatr Endocrinol
Çetinkaya S, Eren E, Erdoğan F, Darendeliler F.   +3 more
europepmc   +1 more source

Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement.

J Clin Endocrinol Metab
Maniatis A, Cutfield W, Dattani M, Deal C, Collett-Solberg PF, Horikawa R, Maghnie M, Miller BS, Polak M, Sävendahl L, Woelfle J.   +10 more
europepmc   +1 more source

Preclinical Investigations of a Novel PEGylated Long-Acting Human Growth Hormone. [PDF]

Drug Des Devel Ther
Wang J, Wang H, Wang R, Zhuang Y, Jiang C, Zhao B, Xu Z, Ma BY.   +7 more
europepmc   +1 more source

Correction to: "Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement".

J Clin Endocrinol Metab
europepmc   +1 more source

Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023. [PDF]

Biomedicines
Martins AC, Oshiro MY, Albericio F, de la Torre BG.   +3 more
europepmc   +1 more source